Trials / Completed
CompletedNCT00035269
New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)
Linezolid in the Treatment of Penicillin-Resistant Streptococcus Pneumoniae Pneumonia: An Open-Label, Non-Comparator Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 230 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 13 Years
- Healthy volunteers
- Not accepted
Summary
This study will treat patients who have a community-acquired pneumonia that is due to a specific bacteria (S. pneumoniae)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Antibiotic |
Timeline
- Start date
- 2001-12-01
- Completion
- 2003-05-01
- First posted
- 2002-05-03
- Last updated
- 2011-04-26
Locations
46 sites across 4 countries: United States, Slovakia, Spain, Taiwan
Source: ClinicalTrials.gov record NCT00035269. Inclusion in this directory is not an endorsement.